Medicare Part B Premium Dips on Alzheimer’s Drug Setback Medicare’s experience with the drug Aduhelm should serve as a wake-up call about both the rising drug costs and FDA’s standards for speeding clearance of medicines, an advocate and a researcher said.
|
Toplista
Hirdetés |
2026. Május 14. Imola, Szervác napja van
